Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016092083> ?p ?o ?g. }
- W2016092083 endingPage "368" @default.
- W2016092083 startingPage "361" @default.
- W2016092083 abstract "To review long-term safety data from the rollover study ETV-901, focusing on adverse events (AEs) with a potential nucleos(t)ide association.The open-label study ETV-901 (AI463901) assessed the safety of entecavir in chronic hepatitis B patients who received entecavir, lamivudine or adefovir monotherapy in previous entecavir Phase II/III studies. Long-term cumulative safety results are based on reported AEs, regardless of causal relationship.Median exposure to entecavir in study ETV-901 was 184 weeks. Commonly reported AEs (≥ 10%) were upper respiratory tract infection, headache and nasopharyngitis. Most AEs were mild to moderate; 203 (19%) patients reported grade 3 - 4 AEs, with 45 (4%) considered related to entecavir. There were 14 (1%) discontinuations due to AEs. On-treatment alanine aminotransferase (ALT) flares were reported in 32 (3%) patients and were associated with a reduction in hepatitis B virus DNA of more than 2 log(10) copies/ml in 25/32 patients. AEs potentially associated with nucleos(t)ide analogs were infrequent, the most common being myalgia (n = 54; 5%) and neuropathy-related AEs (hypoparesthesia and hyperparesthesia, polyneuropathy; n = 42; 4%).Long-term administration of entecavir was associated with low rates of serious AEs, discontinuations due to AEs and ALT flares. AEs potentially associated with nucleos(t)ide use occurred at low rates." @default.
- W2016092083 created "2016-06-24" @default.
- W2016092083 creator A5002183557 @default.
- W2016092083 creator A5003410606 @default.
- W2016092083 creator A5024179985 @default.
- W2016092083 creator A5026830760 @default.
- W2016092083 creator A5039885101 @default.
- W2016092083 creator A5039932124 @default.
- W2016092083 creator A5055770656 @default.
- W2016092083 creator A5058938800 @default.
- W2016092083 creator A5066288177 @default.
- W2016092083 creator A5071098192 @default.
- W2016092083 creator A5083057475 @default.
- W2016092083 date "2012-01-11" @default.
- W2016092083 modified "2023-10-18" @default.
- W2016092083 title "Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901" @default.
- W2016092083 cites W1868572450 @default.
- W2016092083 cites W1964491003 @default.
- W2016092083 cites W1970657877 @default.
- W2016092083 cites W1976104517 @default.
- W2016092083 cites W1983630195 @default.
- W2016092083 cites W1985860298 @default.
- W2016092083 cites W1992949458 @default.
- W2016092083 cites W1993236995 @default.
- W2016092083 cites W1999664635 @default.
- W2016092083 cites W2001604203 @default.
- W2016092083 cites W2007634718 @default.
- W2016092083 cites W2014279976 @default.
- W2016092083 cites W2014837723 @default.
- W2016092083 cites W2022770725 @default.
- W2016092083 cites W2027543203 @default.
- W2016092083 cites W2027897535 @default.
- W2016092083 cites W2031317669 @default.
- W2016092083 cites W2042565956 @default.
- W2016092083 cites W2051976356 @default.
- W2016092083 cites W2055339444 @default.
- W2016092083 cites W2058376942 @default.
- W2016092083 cites W2062680879 @default.
- W2016092083 cites W2075338430 @default.
- W2016092083 cites W2075528292 @default.
- W2016092083 cites W2102293583 @default.
- W2016092083 cites W2108147025 @default.
- W2016092083 cites W2124484286 @default.
- W2016092083 cites W2128922663 @default.
- W2016092083 cites W2139114842 @default.
- W2016092083 cites W2143584498 @default.
- W2016092083 cites W2154488194 @default.
- W2016092083 cites W2161280033 @default.
- W2016092083 cites W2393327590 @default.
- W2016092083 cites W3030265267 @default.
- W2016092083 doi "https://doi.org/10.1517/14740338.2012.653340" @default.
- W2016092083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22233350" @default.
- W2016092083 hasPublicationYear "2012" @default.
- W2016092083 type Work @default.
- W2016092083 sameAs 2016092083 @default.
- W2016092083 citedByCount "54" @default.
- W2016092083 countsByYear W20160920832012 @default.
- W2016092083 countsByYear W20160920832013 @default.
- W2016092083 countsByYear W20160920832014 @default.
- W2016092083 countsByYear W20160920832015 @default.
- W2016092083 countsByYear W20160920832016 @default.
- W2016092083 countsByYear W20160920832017 @default.
- W2016092083 countsByYear W20160920832018 @default.
- W2016092083 countsByYear W20160920832019 @default.
- W2016092083 countsByYear W20160920832020 @default.
- W2016092083 countsByYear W20160920832021 @default.
- W2016092083 countsByYear W20160920832023 @default.
- W2016092083 crossrefType "journal-article" @default.
- W2016092083 hasAuthorship W2016092083A5002183557 @default.
- W2016092083 hasAuthorship W2016092083A5003410606 @default.
- W2016092083 hasAuthorship W2016092083A5024179985 @default.
- W2016092083 hasAuthorship W2016092083A5026830760 @default.
- W2016092083 hasAuthorship W2016092083A5039885101 @default.
- W2016092083 hasAuthorship W2016092083A5039932124 @default.
- W2016092083 hasAuthorship W2016092083A5055770656 @default.
- W2016092083 hasAuthorship W2016092083A5058938800 @default.
- W2016092083 hasAuthorship W2016092083A5066288177 @default.
- W2016092083 hasAuthorship W2016092083A5071098192 @default.
- W2016092083 hasAuthorship W2016092083A5083057475 @default.
- W2016092083 hasConcept C126322002 @default.
- W2016092083 hasConcept C159047783 @default.
- W2016092083 hasConcept C197934379 @default.
- W2016092083 hasConcept C2522874641 @default.
- W2016092083 hasConcept C2776175608 @default.
- W2016092083 hasConcept C2777382497 @default.
- W2016092083 hasConcept C2777869810 @default.
- W2016092083 hasConcept C2778375690 @default.
- W2016092083 hasConcept C2778616394 @default.
- W2016092083 hasConcept C2779517838 @default.
- W2016092083 hasConcept C2780805593 @default.
- W2016092083 hasConcept C3020491458 @default.
- W2016092083 hasConcept C71924100 @default.
- W2016092083 hasConcept C90924648 @default.
- W2016092083 hasConceptScore W2016092083C126322002 @default.
- W2016092083 hasConceptScore W2016092083C159047783 @default.
- W2016092083 hasConceptScore W2016092083C197934379 @default.
- W2016092083 hasConceptScore W2016092083C2522874641 @default.
- W2016092083 hasConceptScore W2016092083C2776175608 @default.